Filter
2846
Text search:
WHO
drug
use
indicators
Featured
Recommendations
230
New Publications
892
Language
Document type
No document type
1792
Studies & Reports
441
Guidelines
303
Strategic & Response Plan
126
Manuals
114
Training Material
32
Fact sheets
18
Situation Updates
13
Infographics
6
Online Courses
1
Countries / Regions
India
170
Kenya
107
Global
103
Uganda
86
Ethiopia
81
Nepal
74
Nigeria
73
Tanzania
63
South Africa
62
Malawi
61
Western and Central Europe
60
Sierra Leone
59
Zambia
57
Ghana
56
Liberia
53
Latin America and the Carribbean
52
Bangladesh
51
Myanmar / Burma
49
Rwanda
45
Namibia
44
Africa
41
Eastern Europe
29
Philippines
28
Lesotho
28
Cambodia
27
Zimbabwe
26
Ukraine
26
South–East Asia Region
26
Asia
24
Indonesia
21
Botswana
20
Congo, Democratic Republic of
17
Senegal
15
Mozambique
14
Eswatini/ Swaziland
14
Burkina Faso
13
Cameroon
10
Haiti
10
East and Southern Africa
10
Russia
10
Pakistan
9
Syria
9
Eastern Europe and Central Asia
8
Brazil
7
Middle East and North Africa
7
Albania
7
Georgia
7
South Sudan
6
Thailand
6
Colombia
6
West and Central Africa
6
Germany
5
Lebanon
5
Sudan
5
Venezuela
5
Laos
5
Vietnam
5
Guinea
4
USA
4
China
4
Benin
4
Western Pacific Region
4
Timor Leste/ East Timor
4
Tajikistan
4
Moldova
4
North America
4
Iraq
3
Jordan
3
Afghanistan
3
Papua New Guinea
3
Peru
3
North Macedonia
3
El Salvador
3
Armenia
3
Mali
2
Côte d’Ivoire / Ivory Coast
2
Morocco
2
Saudi Arabia
2
Turkey
2
Central African Republic
2
Argentina
2
Honduras
2
Bolivia
2
Mexico
2
Sri Lanka
2
Paraguay
2
Bhutan
2
Iran
2
Kyrgyzstan
2
Kazakhstan
2
France
2
United Kingdom
2
Portugal
2
Niger
1
Somalia
1
Ireland
1
Singapore
1
Dominican Republic
1
Serbia
1
Hungary
1
Greece
1
Libya
1
Guatemala
1
Madagascar
1
Nicaragua
1
Chile
1
Poland
1
Palestine
1
North Korea
1
Italy
1
Mongolia
1
Congo-Brazzaville
1
Qatar
1
Bulgaria
1
Estonia
1
Gabon
1
Turkmenistan
1
Jamaica
1
Belgium
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Spain
1
Belarus
1
Belize
1
Costa Rica
1
Panama
1
Authors & Publishers
Publication Years
Category
Countries
1373
Clinical Guidelines
178
Public Health
157
Key Resources
101
Women & Child Health
90
Capacity Building
33
Pharmacy & Technologies
25
Toolboxes
HIV
327
TB
243
Mental Health
187
AMR
156
NTDs
98
COVID-19
68
NCDs
58
Pharmacy
57
Caregiver
56
Malaria
50
Rapid Response
34
Planetary Health
31
Global Health Education
30
Disability
29
Conflict
27
Health Financing Toolbox
21
Ebola & Marburg
20
Refugee
19
2.0 Rapid Response
18
Polio
14
Natural Hazards
7
Cholera
6
Social Ethics
5
Zika
4
Specific Hazards
4
The purpose of this manual is to define a limited number of indicators that will objectively describe the management and use of antimicrobials in hospitals and to provide tools and step-by-step inst
...
The publication conveys the quantitative surveillance results focusing on tobacco use and noncommunicable disease (NCD) related behaviours among youth (13–15 years) in Member States of the WHO Sou
...
The Sustainable Development Goals (SDGs) aim to transform our world. They are a call to action to end poverty and inequality, protect the planet, and ensure that all people enjoy health, justice and prosperity. It is critical that no one is left behind. In 2015, all the countries in the United
...
Sunsari Technical College Journal Oktober 2012
Schools are generally the most popular setting for drug-use-
prevention programmes, and are used both by governmental and
non-governmental agencies. This may be for many reasons: ease of
obtainin
...
This document is based on currently available scientific evidence on treatment for drug use disorders and sets out a framework for the implementation of the Standards, in line with principles of pub
...
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its
...
WHO Pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems
This manual provides a practical method for determining the pharmacovigilance indices. It is designed to be simple and can be understood by any worker in pharmacovigilance without formal training in monitoring and evaluation. Pharmacovigilance as a medical discipline is crucial in preventing medicin
...
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this
...
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has
...
This e-course will guide you through the essentials of latest existing WHO guidelines and policy recommendations on drug-resistant TB. You will also learn more about the rationale behind the
...
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G
...
Constituting the second part of the World Drug Report 2022, the present booklet contains an overview of the global demand for and supply of drugs.
The first chapter of the booklet begins with the latest estimates of the number of people
...
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment
...
In this entry we are looking at smoking, alcohol consumption and the use of illicit drugs. We are studying who is using these substances, how their use
...
The guideline on Drug misuse: opioid detoxification, commissioned by NICE and developed by the National Collaborating Centre for Mental Health, sets out clear, evidence-based recommendations for healthcare staff on how to work with people
...
Version 1.0, 2014-11-21
Introduction:
This document lists TB indicators that can be derived from the recording and reporting tools defined
in Definitions and reporting framework for tuberculosis – 2013 revision (
...